ZW

ZACHARY WILLIAMS

FORBES-TATE · Washington, DC · registered since 2024
Registered · LDAActive

Background

Career
Washington, DC
2024 - present

Specific issues

Issues regarding implementation of the Consolidated Appropriations Act, 2021 (PL 116-260); Issues related to the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program; Issues related to the 340b program.
Budget/Appropriations · 2025 Q1
Issues related to Biosimilars; Issues related to drug pricing; Issues related to the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program; Issues related to the 340b program.
Medical/Disease Research/Clinical Labs · 2025 Q1
Issues related to prescription drug pricing; Issues related to drug pricing; Issues related to the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program; Issues related to the 340b program.
Medicare/Medicaid · 2025 Q1
Issues related to the implementation of international tax and tax reform in the Tax Cuts and Jobs Act (PL 115-97); Issues related to Puerto Rico tax; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program; Issues related to the 340b program.
Taxation/Internal Revenue Code · 2025 Q1
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act.
Medicare/Medicaid · 2025 Q1
Issues related to proposed cuts in the CY 2025 Medicare Physician Fee Schedule proposed rule; Issues related to H.R. 2474 - Strengthening Medicare for Patients and Providers Act; Issues related to H.R. 6371 - Provider Reimbursement Stability Act of 2023; Issues related to S. 4935 - Physician Fee Stabilization Act.
Financial Institutions/Investments/Securities · 2025 Q1

Clients

2024-2025 · 5 filings
$██,███ / qtrUnlock
$██,███ / qtrUnlock
$██,███ / qtrUnlock
2024-2025 · 5 filings
$██,███ / qtrUnlock
2024-2025 · 5 filings
$██,███ / qtrUnlock
2024-2025 · 5 filings
$██,███ / qtrUnlock
2024-2025 · 5 filings
$██,███ / qtrUnlock
2024-2025 · 5 filings
$██,███ / qtrUnlock
2024-2025 · 5 filings
$██,███ / qtrUnlock
2024-2025 · 5 filings
$██,███ / qtrUnlock
2024-2025 · 5 filings
$██,███ / qtrUnlock
2024-2025 · 5 filings
$██,███ / qtrUnlock
$██,███ / qtrUnlock
2024-2025 · 5 filings
$██,███ / qtrUnlock
$██,███ / qtrUnlock
2025 · 2 filings
$██,███ / qtrUnlock
2024 · 4 filings
$██,███ / qtrUnlock

Filing history

2025 Q1
VIZGEN INC.
Q1lda.gov →
2025 Q1
AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION
Q1lda.gov →
2025 Q1
AMGEN USA, INC.
Q1lda.gov →
2025 Q1
ALEXION PHARMACEUTICALS, INC.
Q1lda.gov →
2025 Q1
DIGESTIVE HEALTH PHYSICIANS ASSOCIATION
Q1lda.gov →
2025 Q1
AMERICAN INDEPENDENT MEDICAL PRACTICE ASSOCIATION
Q1lda.gov →
2025 Q1
BIO-RAD LABORATORIES
Q1lda.gov →
2025 Q1
CITY OF BIRMINGHAM, ALABAMA
Q1lda.gov →
2025 Q1
STRATHSPEY CROWN HOLDINGS, LLC
Q1lda.gov →
2025 Q1
SANOFI U.S.
Q1lda.gov →
2025 Q1
DIRECT SUPPLY, INC.
Q1lda.gov →
2025 Q1
VIRPAX PHARMACEUTICALS
Q1lda.gov →
Showing recent filings · full history on lda.gov